ACMG Education Webinar Series: Translating Genes into Health® Digital Edition

Date of Release: July 2, 2024

Expiration Date: July 2, 2026

Credits offered: CME

Estimate time of completion: 5 hours

Specialized events developed by ACMG Committees.

Course Description

The ACMG Webinar Series: Translating Genes into Health® is a collaborative educational initiative designed to showcase the expertise and contributions of ACMG committees while addressing emerging and impactful topics in medical genetics and genomics. This series provides a platform for thought leaders, researchers, and clinicians to engage in meaningful discussions on advancements in genetic testing, clinical applications, ethical considerations, and health equity.

Through interactive, expert-led sessions, participants will gain valuable insights into cutting-edge research, translational genomics, and best practices in patient care. Each session is developed in collaboration with ACMG committees, reflecting their ongoing efforts to shape the future of clinical genetics through education, policy, and innovation.

2024 Webinar Series Topics:

• Obtaining Funding from the Patient-Centered Outcomes Research Institute (PCORI) and Utilizing a Recent PCORI Project to Better Support Black and Hispanic Parents of Children with Disabilities
• Advances in Gene Therapy – 2024 Update
• The Utility and Limitations of Diagnostic Transcriptome RNA Sequencing in Mendelian Disorders
• Classification Investigation – Examining Pathogenicity of DMD Variants Detected on Carrier Screening
• The Ethical Principles Every Geneticist Needs to Know

By attending this series, healthcare professionals will enhance their ability to interpret and apply genetic and genomic data in clinical practice, navigate ethical considerations, and leverage funding opportunities to support patient-centered research and care. This initiative underscores ACMG’s commitment to advancing genetics and genomics education while fostering collaboration across its diverse committee network.

Target Audience

This activity is designed for clinical geneticists, genetic counselors, laboratory professionals, and other healthcare providers involved in the diagnosis and management of genetic conditions. The content is also relevant to researchers and healthcare professionals seeking to stay up to date on emerging advancements and best practices in genetic conditions.

Learning Objectives

At the conclusion of this series, participants should be able to:

• Apply the latest advancements in clinical genetics and genomics to improve patient care, including innovations in gene therapy, diagnostic transcriptome RNA sequencing, and variant classification.
• Evaluate funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI) and identify strategies for supporting historically underserved patient populations through research initiatives.
• Interpret complex genetic findings and assess their clinical utility, limitations, and implications for patient management.
• Analyze ethical principles and challenges in genetic and genomic medicine, ensuring responsible and equitable application of genetic testing and counseling.
• Engage with ACMG committees to gain insights into emerging research, best practices, and collaborative efforts that shape the future of medical genetics and genomics.

Meet the Faculty

Moderators:

Natario Couser, MD FACMG

Associate Professor, Kennedy Krieger Institute

Kevin Mintz, PhD, MS

Postdoctoral fellow, Stanford University, Center for Biomedical Ethics

Kuntal Sen, MD, FACMG

Co-Director, Neurogenetics Clinic Center for Neuroscience and Behavioral Medicine Children’s National Hospital Asst. Prof of Genomics, Pediatrics & Neurology GWU School of Medicine and Health Sciences

Jaya Ganesh, MD, FACMG

Associate Professor, Department of Genetics and Genomic Sciences

Icahn School of Medicine at Mount Sinai

Hong Li, MD, PhD, FACMG

Associate Professor, Emory University

Blake Vuocolo, MS, CGC

Certified Genetic Counselor

Baylor College of Medicine

Tanya N. Eble, MS, CGC

Associate Professor, Department of Molecular and Human Genetics

Baylor College of Medicine

Presenters:

Stephanie Meredith, MA, DrPH

Director of the Lettercase National Center for Prenatal and Postnatal Resources at the University of Kentucky’s Human Development Institute

Murugu Manickam, MD, MPH, FACMG

Clinical Geneticist/Genomicist at Nationwide Children's Hospital

Beth A. Pletcher, MD, FAAP, FACMG

Emeritus Professor, Rutgers New Jersey Medical School, Emeritus Professor, Rutgers New Jersey Medical School

Dwight Koeberl, MD, PhD, FACMG

Division of Medical Genetics, and Department of Molecular Genetics & Microbiology, Duke University School of Medicine

Hadley Smith, PhD, MPSA

Assistant Professor, Harvard Medical School & Harvard Pilgrim Health Care Institute

Harry Layton Lesmana, MD, FAAP, FACMG

Assistant Professor of Molecular Medicine

Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Stephen M. Chrzanowski, MD, PhD

Assistant Professor. Division of Child Neurology, Department of Pediatrics. Department of Neurology. UMass Chan Medical School

Pengfei Liu, PhD

Associate Professor, Baylor College of Medicine

Blake Vuocolo, MS, CGC

Certified Genetic Counselor

Baylor College of Medicine

Kayla Banks, MS, CGC

Community Research Project Director

Parent Project Muscular Dystrophy

Sandra Darilek, MS, CGC

Certified Genetic Counselor, Associate Professor

Baylor College of Medicine

Tanya N. Eble, MS, CGC

Associate Professor, Department of Molecular and Human Genetics

Baylor College of Medicine

Bimal P. Chaudhari, MD, MPH, FACMG

Assistant Professor of Pediatrics, Nationwide Children’s Hospital

Stephanie Malia Fullerton, DPhil

Professor Department of Bioethics & Humanities, University of Washington School of Medicine

AMA PRA Category 1 Credits^TM & CME Other

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

Claiming your Educational Credits

This activity consists of: View content, take a post-test, the test may be taken as often as necessary to achieve a passing score of 80% or better is required to receive credit.  If you do not achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again. Complete the evaluation form.

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

Technical Support:
You can reach us by email at education@acmg.net or call 301-718-9603.
Support Center Hours: Monday – Friday, 9:00 AM – 5:00 PM Eastern Time.

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy

All of the relevant financial relationships listed for these individuals have been mitigated.